| Alexandra Defrance, PA-C | |
|
59 Sycamore St Ste 301, Glastonbury, CT 06033-4536 | |
| (860) 430-2821 | |
| Not Available |
| Full Name | Alexandra Defrance |
|---|---|
| Gender | Female |
| Speciality | Physician Assistant - Surgical |
| Location | 59 Sycamore St Ste 301, Glastonbury, Connecticut |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1144951492 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 363AS0400X | Physician Assistant - Surgical | 030662 (New York) | Secondary |
| 363AS0400X | Physician Assistant - Surgical | 25MP00807400 (New Jersey) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Alexandra Defrance, PA-C 62 Wildwood Ln, Middletown, CT 06457-5198 Ph: (860) 301-9935 | Alexandra Defrance, PA-C 59 Sycamore St Ste 301, Glastonbury, CT 06033-4536 Ph: (860) 430-2821 |
News Archive
A breakthrough study by research teams at Rosalind Franklin University of Medicine and Science and Oregon Health & Science University offers promise for therapeutic management of congenital diseases in utero using designer nucleotide sequences that can simply be injected into the fluid surrounding the developing fetus to potentially treat disabling-to-lethal genetic defects.
In a paper recently uploaded to the preprint server bioRxiv* by Diffley et al. (April 8th, 2021), inhibitors of one essential SARS-CoV-2 non-structural protein are explored, with four compounds, in particular, identified as potential antiviral leads that exhibit synergistic effects with antiviral drug remdesivir.
Cancer Research Technology (CRT), the oncology-focused development and commercialisation company wholly owned by Cancer Research UK, today announce that they have entered into an agreement with AstraZeneca focused on colorectal cancer.
By creating a "map" of histone modifications in fat cells, investigators have discovered two new factors that regulate fat formation, a key step on the road to better understanding obesity, diabetes and other metabolic disorders.
Researchers at the Federal University of São Carlos in Sorocaba have developed a technique to diagnose early-stage multiple sclerosis, a disease of the central nervous system, and distinguish it from neuromyelitis optica, a rare yet severe autoimmune inflammatory process also affecting the central nervous system.
› Verified 1 days ago
Kevin William O'connell, Physician Assistant Medicare: Medicare Enrolled Practice Location: 325 Cedar Ridge Dr, Glastonbury, CT 06033 Phone: 860-930-3053 | |
Mr. Daniel G Mussen, PA-C Physician Assistant Medicare: Accepting Medicare Assignments Practice Location: 320 Western Blvd., Glastonbury, CT 06033 Phone: 860-568-9180 Fax: 860-633-1793 | |
Catherine Brown, PA Physician Assistant Medicare: Accepting Medicare Assignments Practice Location: 330 Western Blvd, Glastonbury, CT 06033 Phone: 860-246-2071 Fax: 860-633-2466 | |
Geoffrey P Robinson, PA Physician Assistant Medicare: Not Enrolled in Medicare Practice Location: 676 Hebron Ave, Glastonbury, CT 06033 Phone: 860-696-2250 Fax: 860-696-2260 | |
Mrs. Kristen Labrencis Mccartney, PA-C Physician Assistant Medicare: Accepting Medicare Assignments Practice Location: 42 Shady Hill Ln, Glastonbury, CT 06033 Phone: 860-965-3329 | |
Erik Libby, PA Physician Assistant Medicare: Accepting Medicare Assignments Practice Location: 84 Glastonbury Blvd, Glastonbury, CT 06033 Phone: 860-652-8883 Fax: 860-652-8887 |